Raymond James Financial Services Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$585K Sell
2024
Q1
$730K Sell
2023
Q4
$936K Sell
2023
Q3
$788K Buy
2023
Q2
$448K Buy
2019
Q2
Sell
2019
Q1
$203K Buy
2016
Q4
Sell
2016
Q3
$592K Buy